Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
Batf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
2008 StandoutScience
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
2010
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
2003 StandoutScienceNobel
A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
2013
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
2019
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
CD4+ Tregs and immune control
2004 StandoutNobel
Active Immunotherapy Combined With Blockade of a Coinhibitory Pathway Achieves Regression of Large Tumor Masses in Cancer-prone Mice
2011
Immunotherapy of cancer in 2012
2012
IRF-7 is the master regulator of type-I interferon-dependent immune responses
2005 StandoutNature
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
The Role of Electrospinning in the Emerging Field of Nanomedicine
2006
Electrospinning polyaniline-contained gelatin nanofibers for tissue engineering applications
2005
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Imaging in the era of molecular oncology
2008 StandoutNature
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Extraction and electrospinning of gelatin from fish skin
2007
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy
2013
Indoleamine 2,3‐dioxygenase contributes to tumor cell evasion of T cell‐mediated rejection
2002
A self-assembly pathway to aligned monodomain gels
2010
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
2007
Functional electrospun nanofibrous scaffolds for biomedical applications
2007
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Cross-Presentation of Cell-Associated Antigens by Dendritic Cells
2003
An essential role for Scurfin in CD4+CD25+ T regulatory cells
2003 StandoutNobel
Characterisation of electrospun polystyrene scaffolds for three-dimensional in vitro biological studies
2006
In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth
2008
Immunotherapy and chemotherapy — a practical partnership
2005
Strategies for immunotherapy of cancer
2000
Nanofiber technology: Designing the next generation of tissue engineering scaffolds
2007
Surface engineering approaches to micropattern surfaces for cell-based assays
2006
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
CD40 Triggering of Heterodimeric IL-12 p70 Production by Dendritic Cells In Vivo Requires a Microbial Priming Signal
2000
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Cytokine-secreting tumor cell vaccines
2000
Electrospinning: A fascinating fiber fabrication technique
2010 Standout
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
2007
Electrospinning: A Fascinating Method for the Preparation of Ultrathin Fibers
2007 Standout
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance
2002 StandoutNobel
In vivoblockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
1999 StandoutNobel
Functional Supramolecular Polymers
2012 StandoutScience
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo
2006
Naturally Arising CD4+Regulatory T Cells for Immunologic Self -Tolerance and Negative Control of Immune Responses
2003 StandoutNobel
Advances in engineering hydrogels
2017 StandoutScience
Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN
2004
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
2011 Science
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Supramolecular Double-Helix Formation by Diastereoisomeric Conformations of Configurationally Enantiomeric Macrocycles
2016 StandoutNobel
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
2001 StandoutNobel
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Aligned Carbon Nanotube–Based Flexible Gel Substrates for Engineering Biohybrid Tissue Actuators
2015
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Monitoring contractility in cardiac tissue with cellular resolution using biointegrated microlasers
2020
CD4+ Tregs and immune control
2004 StandoutNobel
Activation of APCs Through CD40 or Toll-Like Receptor 9 Overcomes Tolerance and Precipitates Autoimmune Disease
2002
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Cross-presentation of tumor antigens by bone marrow–derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression
2001
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Immunosuppressive Strategies that are Mediated by Tumor Cells
2006
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
2002 StandoutNobel
Metabolic reprogramming and cancer progression
2020 StandoutScience
Conversion of Alloantigen-Specific CD8+ T Cell Anergy to CD8+ T Cell Priming through In Vivo Ligation of Glucocorticoid-Induced TNF Receptor
2006 StandoutNobel
Direct in Vitro Electrospinning with Polymer Melts
2006
Cancer Genome Landscapes
2013 StandoutScience
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
2003
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Genetics and biology of pancreatic ductal adenocarcinoma
2016
Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo
2000
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Magnetic‐Field‐Switchable Laser via Optical Pumping of Rubrene
2021 StandoutNobel
Antibody to Langerin/CD207 localizes large numbers of CD8α + dendritic cells to the marginal zone of mouse spleen
2009 StandoutNobel
Processing technologies for poly(lactic acid)
2008 Standout
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
1999 StandoutNobel
Reciprocal Changes in Tumor Antigenicity and Antigen-specific T Cell Function during Tumor Progression
2004
Works of Harold Bien being referenced
Stimulating Cardiac Muscle by Light
2011
Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40
1999
Electrospun fine-textured scaffolds for heart tissue constructs
2005
Acoustic micromachining of three-dimensional surfaces for biological applications
2004
The Role of Cardiac Tissue Alignment in Modulating Electrical Function
2007
PI3K Regulation of RAC1 Is Required for KRAS-Induced Pancreatic Tumorigenesis in Mice
2014
OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology
2016
Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens.
2003